SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Thursday reported a loss of $20.6 million in its fiscal fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 32 cents.

The maker of synthetic DNA for the biotechnology industry posted revenue of $126.6 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $123.4 million.

For the year, the company reported a loss of $130.2 million, or $2.08 per share. Revenue was reported as $459.4 million.

For the current quarter ending in December, Twist Bioscience said it expects revenue in the range of $130 million to $132 million.

The company expects full-year revenue in the range of $550 million to $560 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST